Conclusions: Our findings provide valuable information for personalized pain treatment after LAC, in which the C allele of the rs2076222 SNP is associated with lower opioid sensitivity and/ or higher pain sensitivity and requires more opioid analgesic after LAC.
PT643

Potassium and TRP Channels Are Involved in Analgesic Effects of NSAIDs in Tail Immersion Test
Nonsteroidal anti-inflammatory drugs (NSAIDs), which main mechanism is the inhibition of cyclooxygenases (COXs), are commonly used in management of pain, fever and inflammation. In recent years, it has been asserted that NSAIDs induce central antinociception via various central analgesic mechanisms (1-2). Transient receptor potential (TRP) channels and potassium (K + ) channels are widely distributed in the central and peripheral regions related with pain (3) (4) (5) .
It is aimed to investigate the possible involvement of Kv7 potassium channels and TRP channels in antinociceptive mechanism of central action of selected NSAIDs, dipyrone (500 mg/kg, i.p.), etodolac (70 mg/kg, i.p.), ketoprofen (50 mg/ kg, i.p.) and diclofenac (50 mg/kg, i.p.) by using tail-immersion test in mice. Mice were pre-treated with 3 mg/kg (i.p.) ruthenium red (RR), non-competitive TRPV1 antagonist, and XE-911 (1 mg/kg, i.p.), the potent and selective blocker of Kv7 channel, 30 and 15 minutes before NSAIDs administration, respectively. The tail withdrawal responses to thermal stimuli (52.5 ± 0.2 °C hot water) (6) were measured 45 minutes after NSAIDs administration.
The results of experiments showed that dipyrone, etodolac, diclofenac and ketoprofen exhibit statistically significant analgesia. Dipyrone and etodolac induced antinociception was significantly reversed (P<0.001, P<0.01) by pre-treatment with XE-911 while dipyrone, etodolac and also ketoprofen induced antinociception was significantly reversed (P<0.001, P<0.001, P<0.01) by pre-treatment with RR.
In conclusion, Kv7 channels are involved in the central analgesic activity of dipyrone and etodolac. TRP channels play a role in central antinociceptive effects of dipyrone, etodolac and ketoprofen. It may be suitable approach to use these agents as adjunctive therapeutics with other central analgesics to provide more effective therapy with less side-effects.
(Project no: 1409S394, supported by the Anadolu University Scientific Research Projects Unit). 1 . However, the studies focused on the analgesic effect of this polyphenolic are limited 2 and the action mechanisms of PCA still remain unclear.
Previously, we found that PCA has a central analgesic effect in hot-plate and tail-immersion test at the doses of 75, 150 and 300 mg/kg
